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Figure 1 MRI of the pelvis showing pelvic fascial fluid and
edema with a hyperintense signal of the fascia surrounding the
muscles in the pelvis, suggestive of myofasciitis.hard to initially evaluate and treat. Necrotizing fasciitis
should be considered in the differential diagnosis of severe
abdominal pain.
Conflict of interest: No conflict of interest to declare.
References
1. Huljev D. Necrotizing fasciitis of the abdominal wall with lethal
outcome: a case report. Hernia 2007;11:271—8.
2. Marron CD, McArdle GT, Rao M, Sinclair S, Moorehead J. Perfo-
rated carcinoma of the cecum presenting as necrotizing fasciitis
of the abdominal wall, the key to early diagnosis and manage-
ment. BMC Surgery 2006;6:11.
3. Sharma D, Dalencourt G, Bitterly T, Benotti PN. Small intestinal
perforation and necrotizing fasciitis after abdominal liposuction.
Aesthetic Plast Surg 2006;30:712—6.
4. MacLean AA, Miller G, Bamboat ZM, Hiotis K. Abdominal wall
necrotizing fasciitis from dislodged percutaneous endoscopic
gastrostomy tubes: a case series. Am Surg 2004;70:827—31.
5. Alvarez-Zepeda C, Hermansen-Truan C, Valencia-Lazo O, Azolas-
Marcos R, Gatica-Jimenez F, Castillo-Avendano J. Necrotizing
fasciitis of the abdominal wall secondary to a perforated sigmoid
diverticulum in a Spiegel’s hernia. A case report. Cir Cir
2005;73:133—6.
6. Masaki F, Gozo N, Yuuichi H, Hirosi I, Osamu M, Tsuneyuki Y.
Necrotizing fasciitis secondary to intraabdominal infec-tion in Crohn’s disease. J Clin Gastroenterol 2005;39:
448—9.
7. Marron CD, Khadim M, McKay D, Mackle EJ, Peyton JW. Amyand’s
hernia causing necrotizing fasciitis of the anterior abdominal
wall. Hernia 2005;9:381—3.
8. Praba-Egge AD, Lanning D, Broderick TJ, Yelon JA. Necrotizing
fasciitis of the chest and abdominal wall arising from an
empyema. J Trauma 2004;56:1356—61.
9. Terzi C, Bacakoglu A, Unek T, Ozkan MH. Chemical necrotizing
fasciitis due to household insecticide injection: is immediate
radical surgical debridement necessary? Hum Exp Toxicol
2002;21:687—90.
10. Billiemaz K, Lavocat MP, Teyssier G, Chavrier Y, Allard D, Varlet F.
Varicella complicated with necrotizing fasciitis caused by group
A hemolytic Streptococcus. Arch Pediatr 2002;9:262—5.
11. Krowlikowski A, Gowri V, Radha K. Necrotizing fasciitis of abdom-
inal wall after cesarean section. Saudi Med J 2000;21:399—400.
12. Roy PK, Patel SC, Kataria YP. Necrotizing fasciitis of abdominal
wall in AIDS. Dig Dis Sci 2001;46:1139—42.
13. Fujiwara H, Nomura H, Yasuda K, Kuroda D, Kato M, Ohyanagi H.
Acute appendicitis complicated with necrotizing soft tissue
infections in the elderly: report of a case. Hepatogastroenter-
ology 1999;46:1702—5.
14. Rehman A, Walker M, Kubba H, Jayatunga AP. Necrotizing fas-
ciitis following gallbladder perforation. J R Coll Surg Edinb
1998;43:357.
15. Jansen M, Schippers E, Schumpelick V. Necrotizing fasciitis after
laparoscopic cholecystectomy. Chirurg 1998;69:667—8.
16. Ulloa-Gutierrez R, Rodriguez-Calzada H, Quesada L, Arguello A,
Avilla-Aguero ML. Is it acute omphalitis or necrotizing fasciitis?
Report of three fatal cases. Pediatr Emerg Care 2005;21:600—2.
17. Ignacio RC, Falcone Jr RA, Warner BW. Necrotizing fasciitis: a
rare complication of neonatal necrotizing enterocolitis. J
Pediatr Surg 2005;40:1805—7.
Hamed A. Shabaneh Al-Tamimi*
Lee Thomas
Department of Internal Medicine,
Division of Gastroenterology,
Texas Tech University Health Sciences Center,
3601 4th Street, Lubbock, Texas 79430, USA
*Corresponding author. Tel.: +1 806 743 3155;
fax: +1 806 743 3148
E-mail address: hamed.shabanehaltamimi@ttuhsc.edu
(H.A.S. Al-Tamimi)
Corresponding Editor: James Muller, Pietermaritzburg,
South Africa
29 May 2007
doi:10.1016/j.ijid.2007.08.004Septicemia caused by Corynebacterium mac-
ginleyi: a rare form of extraocular infection
Non-diphtheria Corynebacterium species have emerged as
nosocomial pathogens and cause diseases in risk populations,
such as the immunocompromised and patients with indwel-
ling medical devices.1 Recognized cases of bacteremia with
non-diphtheria Corynebacterium spp have become more pre-
valent.1 We report herein the first case of Corynebacteriummacginleyi septicemia in an immunocompromised adult
patient, which resulted in death.
A 73-year old male was hospitalized with headaches,
disorientation, instability, and vomiting. The patient had
previously been diagnosed with non-Hodgkin lymphoma,
hypertension, and type 2 diabetes mellitus. Physical exam-
ination showed partial disorientation and globally diminished
osteomuscular reflexes. The patient had no motor or sensory
deficits and had no signs of meningococcal irritation.
334 CorrespondenceCardiopulmonary and abdominal examinations were normal.
An electrocardiogram showed signs of earlier myocardial
ischemia. Laboratory studies showed a hemoglobin level of
7.9 g/dl, hematocrit value of 23.6%, and normal platelet and
white blood cell counts. Pancreatic and liver function tests
were normal. Cerebrospinal fluid (CSF) analysis revealed
10  106 cells/l (mononuclear), glycorrhachia 94 mg/l (gly-
cemia 154 mg/dl), and a total protein count of 1.1 g/l.
Treponemal tests, Borrelia burgdorferi, and Brucella serol-
ogy in samples from serum and CSF were also found to be
negative. The results of serological tests for the human
immunodeficiency virus were all negative. Herpes simplex
virus IgM, cytomegalovirus IgM and IgG, and measles IgM and
IgG were negative. However, herpes simplex virus IgG was
positive. Computed tomography showed bilateral hypoden-
sity and periventricular lesions. Multiple high-density signals
in both cerebral hemispheres, the cerebellum, and pons were
enhanced after endovascular contrasts. Urine culture was
negative. On the fifth day of hospitalization, blood cultures
(three out of three aerobic and anaerobic sets) were found to
be positive. Small colonies were observed on the Columbia
agar plate supplemented with 5% sheep blood. Colonies
consisted of Gram-positive pleomorphic rods. The isolate
was sub-cultured again on the samemediumwith andwithout
1% (vol/vol) of Tween 80 added at 37 8C in a 5% CO2 enriched
atmosphere. Optimal growth of the strain was shown after
72 hours with Tween 80. Identification was performed with
the API Coryne system (bioMe´rieux, France) together with
API Coryne database 2.0 following the manufacturer’s
instructions. The results identified Corynebacterium
macginleyi with a 0.87 T value. Culture of the CSF for
bacteria was negative. The antimicrobial susceptibility pat-
terns were determined by agar diffusion tests,2 and the
minimal inhibitory concentrations (MIC) were determined
by E-test (AB Biodisk, Sweden) on Mueller—Hinton blood agar
supplemented with 5% sheep blood (Becton Dickinson). The
isolate was sensitive to b-lactams (except penicillin G),
glycopeptides, tetracycline, rifampin, and gentamicin but
resistant to co-trimoxazole, quinolones, clindamycin, tobra-
mycin, and erythromycin. A corticosteroid, ceftazidime, and
clindamycin high-dose treatment was established on the
fourth day of admission due to the onset of fever and
leukocytosis. The patient deteriorated, showing persistent
fever, a diminished level of consciousness, and septic shock.
Antimicrobial susceptibility data were not available before
the patient’s death and therefore effective treatment could
not be applied. Necropsy showed an intravascular non-Hodg-
kin lymphoma with central nervous system and systemic
involvement. Septic shock, acute respiratory distress syn-
drome, and acute myocardial disease (with less than a
48-hour evolution, probably related to hemodynamic dete-
rioration due to previous heart disease) were the final causes
of death.
In 1995, Riegel et al.3 were the first to establish the
existence of Corynebacterium macginleyi. When this micro-
organism was first isolated it was defined as an exclusively
conjunctival pathogen.4 However, in 2002, Villanueva et al.
published the first case of infection in the urinary tract of a
patient with a permanent bladder catheter.5 In 2003, two
more cases of extraconjunctival infection with C. macgin-
leyi were documented: one of them was an intravenous
catheter-related infection6 and the other was the causalagent of infectious endocarditis.7 The number of isolates
from conjunctiva swabs (n = 28, 90%) suggests that the
ocular region is the main habitat for this microorganism,
although there has been no systematic examination of this
bacterium in any parts of the body other than the throat and
conjunctiva.8,9
Avariety of antibiotic regimens havebeenused successfully
in the management of extraconjunctival cases (glycopep-
tides,5 beta-lactams,6 beta-lactams with aminoglycosides,7
and beta-lactams with clindamycin in the present report).
The susceptibility of the analyzed strains appears to be
different. The strain isolated in the catheter-related infec-
tion6 was resistant to a greater number of antimicrobials
(beta-lactams, beta-lactams with inhibitors, quinolones,
monobactams, gentamicin, macrolides, co-trimoxazole, and
lincosamides) and it was only sensitive to vancomycin, netil-
micin, and tetracycline. The other three reported strains (one
from a urinary tract infection,5 one the agent of infectious
endocarditis,7 and the one found in the present report) were
sensitive to beta-lactams (except for penicillin, in this case
report), rifampin, and glycopeptides and they were resistant
to quinolones, lincosamides, and co-trimoxazole.With respect
to the aminoglycosides, two out of the three cases were
resistant to tobramycin and susceptible to gentamicin,
while only one case was susceptible to erythromycin.5 The
susceptibility patterns of strains isolated in eye swabs bear a
greater resemblance to each other. In a study by Joussen
et al.,10 66% of the strains were sensitive to chloramphenicol.
Giammanco et al.4 described an isolate that was susceptible
to a group of antimicrobials: beta-lactams with and without
inhibitors, macrolides, aminoglycosides, glycopeptides, qui-
nolones, lincosamides, rifampin, tetracycline, and chloram-
phenicol.
Even though the patient described in our case most prob-
ably died of intravascular non-Hodgkin lymphoma and acute
myocardial diseases, the potential virulence of C. macginleyi
must be considered when it is isolated in pure culture.
Cases of ocular infections related to Corynebacterium spp
are probably underreported in the literature. This may be
due to underestimation of the possible association between
ocular infections and coryneform bacteria. Isolations in pure
culture samples, its discovery in patients with indwelling
catheters, its presence in sterile tissues and/or urine, and
certain clinical signs in immunocompromised patients,
should not be underestimated. The increasing number of
reported infections with C. macginleyi and the continued
growth in the number of immunocompromised patients
suggests that infection with this pathogen is likely to become
more widespread. More information is needed on the
factors that predispose patients to systemic infection and
on the primary site of infection, as well as other pathogenic
properties of C. macginleyi. Despite the limited number of
isolates reported and the incomplete available data, the
literature suggests that vancomycin should be the prefer-
red treatment for non-ocular C. macginleyi infections. If
glycopeptides cannot be used, the results of susceptibility
testing should be used to determine another treatment
option.
This case was presented in part at the 12th International
Congress on Infectious Diseases, Lisbon, Portugal, June 15—
18, 2006.
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doi:10.1016/j.ijid.2007.07.004Nocardia cyriacigeorgica: pulmonary infection
in a patient with Basedow—Graves disease and a
short review of reported cases
Nocardia species are aerobic and saprophytic actinomy-
cetes found all around the world. They invade the human
body from the environment via trauma and the respiratory
tract, and cause cutaneous, pulmonary, and systemic
nocardiosis in humans. There is no age, ethnic group,
or geographic variation in nocardiosis caused by the dif-
ferent Nocardia species, and the male to female ratio
for infection is 3 to 1.1 Nocardiosis is a rare infection
and almost half of all cases are immunocompromised
subjects.2—7
The taxonomy of Nocardia species is a complex issue and
more than 30 different species have been reported to date.8
The morphologic and phenotypic characterization of these
species is difficult and time-consuming, hence they have
been grouped mainly on the basis of their pattern of drug
resistance (types I—VI). Nocardia asteroides drug pattern
type VI has recently been identified as Nocardia cyriacigeor-
gica by use of the 16S rRNA gene amplification method.
Therefore, N. cyriacigeorgica is not really a new species,
but a new name given to a relatively common species.9,10 Thisbacterium was originally described by Yassin et al. with the
name N. cyriacigeorgici;11 its name was subsequently chan-
ged to N. cyriacigeorgica.
Few invasive forms of Nocardia species have been
reported in the literature.12—22 The case described herein
is the first in the literature involving pulmonary N. cyria-
cigeorgica infection in an immunocompromised patient
with Basedow—Graves disease. We also review the pre-
viously reported cases of N. cyriacigeorgica infections in
humans.
The case was a 37-year-old man who was started on
propylthiouracil treatment, 450 mg daily, for treatment of
Basedow—Graves disease. After approximately one year, an
orbital computerized tomography (CT) scan was performed,
and findings resembling a thyroid orbitopathy were found. He
was started on methylprednisolone treatment, 96 mg daily,
which was gradually tapered and ceased a month later; he
developed diabetes mellitus secondary to corticosteroid
treatment, which was controlled with appropriate diet and
gliclazide treatment.
In July 2003 following consultation at the ophthalmol-
ogy department, methylprednisolone treatment, 48 mg
daily, was started once more. In September 2003, while
under the corticosteroid treatment, he was admitted to
